{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:55:51Z","timestamp":1792295751846,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"DOI":"10.1007\/s11882-025-01243-4","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T06:27:48Z","timestamp":1768026468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Biologics in Chronic Rhinosinusitis with Nasal Polyps: The Otolaryngologist\u2019s Perspective"],"prefix":"10.1007","volume":"26","author":[{"given":"Michael F.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-3150","authenticated-orcid":false,"given":"Brent A.","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"3","key":"1243_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2020.01.020","volume":"145","author":"C Bachert","year":"2020","unstructured":"Bachert C, Zhang N, Cavaliere C, Weiping W, et al. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145(3):725\u201339. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.020.","journal-title":"J Allergy Clin Immunol"},{"issue":"10209","key":"1243_CR2","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638\u201350.","journal-title":"Lancet"},{"issue":"3","key":"1243_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.11.003","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of Omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595\u2013605. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.003.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1243_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","volume":"149","author":"P Gevaert","year":"2022","unstructured":"Gevaert P, Saenz R, Corren J, et al. Long-term efficacy and safety of Omalizumab for nasal polyposis in an open-label extension study. J Allergy Clin Immunol. 2022;149(3):957\u201365.e3. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.045","journal-title":"J Allergy Clin Immunol"},{"key":"1243_CR5","doi-asserted-by":"publisher","unstructured":"Han JK, Bachert C, Fokkens W, SYNAPSE study investigators, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9(10):1141\u201353. https:\/\/doi.org\/10.1016\/S2213-2600(21)00097-7.","DOI":"10.1016\/S2213-2600(21)00097-7"},{"issue":"4","key":"1243_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","volume":"149","author":"C Bachert","year":"2022","unstructured":"Bachert C, Han JK, Desrosiers MY, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309\u201317. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.030. .e12.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1243_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11882-024-01186-2","volume":"25","author":"E De Corso","year":"2024","unstructured":"De Corso E, Hellings PW, Fokkens WJ, et al. Thymic stromal lymphopoietin (TSLP): evidence in respiratory epithelial-driven diseases including chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep. 2024;25(1):7. https:\/\/doi.org\/10.1007\/s11882-024-01186-2.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"12","key":"1243_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","volume":"392","author":"BJ Lipworth","year":"2025","unstructured":"Lipworth BJ, Han JK, Desrosiers M, et al. Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps. N Engl J Med. 2025;392(12):1178\u201388. https:\/\/doi.org\/10.1056\/NEJMoa2414482.","journal-title":"N Engl J Med"},{"issue":"2","key":"1243_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/alr.23059","volume":"13","author":"A Miglani","year":"2023","unstructured":"Miglani A, Soler ZM, Smith TL, Mace JC, Schlosser RJ. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. 2023;13(2):116\u201328. https:\/\/doi.org\/10.1002\/alr.23059","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"1243_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/alr.23562","volume":"15","author":"AS Hom\u00f8e","year":"2025","unstructured":"Hom\u00f8e AS, Aan\u00e6s K, Tidemandsen JE, et al. Superior benefits of combining mepolizumab with sinus surgery compared to mepolizumab alone: results from a randomised 6-Month trial. Int Forum Allergy Rhinol. 2025;15(7):724\u201333. https:\/\/doi.org\/10.1002\/alr.23562","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"1243_CR11","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1002\/lary.28648","volume":"131","author":"GA Scangas","year":"2021","unstructured":"Scangas GA, Wu AW, Ting JY, et al. Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope. 2021;131(1):E26-33. https:\/\/doi.org\/10.1002\/lary.28648.","journal-title":"Laryngoscope"},{"issue":"2","key":"1243_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/alr.22487","volume":"10","author":"CA Loftus","year":"2020","unstructured":"Loftus CA, Soler ZM, Koochakzadeh S, et al. Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors. Int Forum Allergy Rhinol. 2020;10(2):199\u2013207. https:\/\/doi.org\/10.1002\/alr.22487.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"1243_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","volume":"61","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ, Viskens AS, Backer V, et al. EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61(3):194\u2013202. https:\/\/doi.org\/10.4193\/Rhin22.489.","journal-title":"Rhinology"},{"issue":"3","key":"1243_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","volume":"62","author":"WJ Fokkens","year":"2024","unstructured":"Fokkens WJ, De Corso E, Backer V, et al. EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024;62(3):287\u201398. https:\/\/doi.org\/10.4193\/Rhin23.415.","journal-title":"Rhinology"},{"issue":"Suppl 1","key":"1243_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/ohn.1344","volume":"173","author":"SC Payne","year":"2025","unstructured":"Payne SC, McKenna M, Buckley J, et al. Clinical practice guideline: adult sinusitis update. Otolaryngol Head Neck Surg. 2025;173(Suppl 1):S1-56. https:\/\/doi.org\/10.1002\/ohn.1344.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"Suppl 2","key":"1243_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/ohn.1287","volume":"172","author":"JJ Shin","year":"2025","unstructured":"Shin JJ, Wilson M, McKenna M, et al. Clinical practice guideline: surgical management of chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2025;172(Suppl 2):S1-47. https:\/\/doi.org\/10.1002\/ohn.1287.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"1243_CR17","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/all.14408","volume":"75","author":"SF Seys","year":"2020","unstructured":"Seys SF, De Bont S, Fokkens WJ, et al. Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mysinusitiscoach project by EUFOREA. Allergy. 2020;75(11):2867\u201378. https:\/\/doi.org\/10.1111\/all.14408.","journal-title":"Allergy"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-025-01243-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T06:27:48Z","timestamp":1768026468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-025-01243-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1007\/s11882-025-01243-4","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}